In this report, our team research the global Next Generation Diabetes Therapy and Drug Delivery market by type, application, region and manufacturer 2013-2018 and forcast 2019-2024. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Next Generation Diabetes Therapy and Drug Delivery in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Next Generation Diabetes Therapy and Drug Delivery market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma Corp
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Next Generation Diabetes Therapy and Drug Delivery for each application, including
Diagnostic/Clinics
ICUs
Home Healthcare
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Next Generation Diabetes Therapy and Drug Delivery Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Next Generation Diabetes Therapy and Drug Delivery Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 Abbott Laboratories
4.1.1 Abbott Laboratories Profiles
4.1.2 Abbott Laboratories Product Information
4.1.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.1.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.2 Medtronic
4.2.1 Medtronic Profiles
4.2.2 Medtronic Product Information
4.2.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.2.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.3 Sanofi
4.3.1 Sanofi Profiles
4.3.2 Sanofi Product Information
4.3.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.3.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.4 Novo Nordisk
4.4.1 Novo Nordisk Profiles
4.4.2 Novo Nordisk Product Information
4.4.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.4.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.5 MannKind Corporation
4.5.1 MannKind Corporation Profiles
4.5.2 MannKind Corporation Product Information
4.5.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.5.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.6 Enteris BioPharma
4.6.1 Enteris BioPharma Profiles
4.6.2 Enteris BioPharma Product Information
4.6.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.6.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.7 Dexcom
4.7.1 Dexcom Profiles
4.7.2 Dexcom Product Information
4.7.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.7.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.8 Senseonics Holding
4.8.1 Senseonics Holding Profiles
4.8.2 Senseonics Holding Product Information
4.8.3 Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.8.4 Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.9 Medtech
4.9.1 Medtech Profiles
4.9.2 Medtech Product Information
4.9.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.9.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.10 Johnson & Johnson
4.10.1 Johnson & Johnson Profiles
4.10.2 Johnson & Johnson Product Information
4.10.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Business Performance
4.10.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Business Development and Market Status
4.11 Synertech
4.12 Zosano Pharma Corp
4.13 Sanofi
4.14 Novo Nordisk
4.15 MannKind Corporation
6.1.1 Published Date: Jun. 2019 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share of Manufacturers 2013-2019
5 Market Performance for Manufacturers
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Market Share by Manufacturers 2013-2018
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Market Share by Manufacturers 2013-2018
5.3 Global Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) of Manufacturers 2013-2018
5.4 Global Next Generation Diabetes Therapy and Drug Delivery Gross Margin of Manufacturers 2013-2018
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share of Manufacturers 2013-2018
6.1.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share of Manufacturers 2013-2018
6.1.3 North America Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) of Manufacturers 2013-2018
6.1.4 North America Next Generation Diabetes Therapy and Drug Delivery Gross Margin of Manufacturers 2013-2018
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share of Manufacturers 2013-2018
6.2.2 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share of Manufacturers 2013-2018
6.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) of Manufacturers 2013-2018
6.2.4 Europe Next Generation Diabetes Therapy and Drug Delivery Gross Margin of Manufacturers 2013-2018
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share of Manufacturers 2013-2018
6.3.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share of Manufacturers 2013-2018
6.3.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) of Manufacturers 2013-2018
6.3.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Gross Margin of Manufacturers 2013-2018
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share of Manufacturers 2013-2018
6.4.2 South America Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share of Manufacturers 2013-2018
6.4.3 South America Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) of Manufacturers 2013-2018
6.4.4 South America Next Generation Diabetes Therapy and Drug Delivery Gross Margin of Manufacturers 2013-2018
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share of Manufacturers 2013-2018
6.5.2 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share of Manufacturers 2013-2018
6.5.3 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) of Manufacturers 2013-2018
6.5.4 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Gross Margin of Manufacturers 2013-2018
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Regions and Countries 2013-2018
7.1.1 World Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Regions 2013-2018
7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
7.1.2.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Countries 2013-2018
7.1.2.2 North America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Countries 2013-2018
7.1.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Countries 2013-2018
7.1.2.4 South America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Countries 2013-2018
7.1.2.5 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Share by Countries 2013-2018
7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
7.2.2.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share by Countries 2013-2018
7.2.2.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share by Countries 2013-2018
7.2.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share by Countries 2013-2018
7.2.2.4 South America Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share by Countries 2013-2018
7.2.2.5 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (M USD) and Share by Countries 2013-2018
7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
7.3.1 World Price (USD/Unit) by Regions 2013-2018
7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
7.3.2.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) by Countries 2013-2018
7.3.2.2 North America Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) by Countries 2013-2018
7.3.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) by Countries 2013-2018
7.3.2.4 South America Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) by Countries 2013-2018
7.3.2.5 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) by Countries 2013-2018
7.4 World Gross Margin by Regions and Countries 2013-2018
7.4.1 World Gross Margin by Regions 2013-2018
7.4.2 Regional Gross Margin and Share by Countries 2013-2018
7.4.2.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Gross Margin and Share by Countries 2013-2018
7.4.2.2 North America Next Generation Diabetes Therapy and Drug Delivery Gross Margin and Share by Countries 2013-2018
7.4.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Gross Margin and Share by Countries 2013-2018
7.4.2.4 South America Next Generation Diabetes Therapy and Drug Delivery Gross Margin and Share by Countries 2013-2018
7.4.2.5 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Gross Margin and Share by Countries 2013-2018
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3 North America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4 Europe Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5 South America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Diagnostic/Clinics Industry
11.2 ICUs Industry
11.3 Home Healthcare Industry
12 Market Forecast 2019-2024
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
12.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
12.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) and Growth Rate 2019-2024
12.1.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.5 Europe Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.6 South America Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.7 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
12.2.1 Overall Market Performance
12.2.2 Inhalable Insulin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.3 Oral Insulin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.4 Insulin Patches Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.5 CGM Systems Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3 Sales by Application 2019-2024
12.3.1 Overall Market Performance
12.3.2 Diagnostic/Clinics Sales and and Growth Rate 2019-2024
12.3.3 ICUs Sales and and Growth Rate 2019-2024
12.3.4 Home Healthcare Sales and and Growth Rate 2019-2024
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Price (USD/Unit) Trend 2019-2024
12.4.2 Global Next Generation Diabetes Therapy and Drug Delivery Gross Profit Trend 2019-2024
13 Conclusion
List of Tables and Figures
Figure Product Picture of Next Generation Diabetes Therapy and Drug Delivery
Table Product Specifications of Next Generation Diabetes Therapy and Drug Delivery
Table Manufacturers List in the Report
Table Manufacturers Market Share 2013-2018
Table Regions Overview in the Report
Table Product Type and Standard
Table Type Overview
Table Product Application and Standard
Table Application Overview in the Report
Figure Industry Chain Structure of Next Generation Diabetes Therapy and Drug Delivery
Table Industry News List of Next Generation Diabetes Therapy and Drug Delivery
Figure New Project SWOT Analysis of Next Generation Diabetes Therapy and Drug Delivery
Table World 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Type
Figure World Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2013
Figure World Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2018
Table World 2013-2018 Next Generation Diabetes Therapy and Drug DeliveryRevenue (M USD) by Type
Figure World Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2013
Figure World Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2018
Table World Inhalable Insulin Sales (K Units) and Growth Rate
Figure World Inhalable Insulin Sales (K Units) and Growth Rate
Table World Inhalable Insulin Revenue (M USD) and Growth Rate
Figure World Inhalable Insulin Revenue (M USD) and Growth Rate
Table World Oral Insulin Sales (K Units) and Growth Rate
Figure World Oral Insulin Sales (K Units) and Growth Rate
Table World Oral Insulin Revenue (M USD) and Growth Rate
Figure World Oral Insulin Revenue (M USD) and Growth Rate
Table World Insulin Patches Sales (K Units) and Growth Rate
Figure World Insulin Patches Sales (K Units) and Growth Rate
Table World Insulin Patches Revenue (M USD) and Growth Rate
Figure World Insulin Patches Revenue (M USD) and Growth Rate
Table World CGM Systems Sales (K Units) and Growth Rate
Figure World CGM Systems Sales (K Units) and Growth Rate
Table World CGM Systems Revenue (M USD) and Growth Rate
Figure World CGM Systems Revenue (M USD) and Growth Rate
Table North America 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Type
Figure North America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2013
Figure North America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2018
Table North America 2013-2018 Next Generation Diabetes Therapy and Drug DeliveryRevenue (M USD) by Type
Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share (%) by Type in 2013
Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share (%) by Type in 2018
Table North America Inhalable Insulin Sales (K Units) and Growth Rate
Figure North America Inhalable Insulin Sales (K Units) and Growth Rate
Table North America Inhalable Insulin Revenue (M USD) and Growth Rate
Figure North America Inhalable Insulin Revenue (M USD) and Growth Rate
Table North America Oral Insulin Sales (K Units) and Growth Rate
Figure North America Oral Insulin Sales (K Units) and Growth Rate
Table North America Oral Insulin Revenue (M USD) and Growth Rate
Figure North America Oral Insulin Revenue (M USD) and Growth Rate
Table North America Insulin Patches Sales (K Units) and Growth Rate
Figure North America Insulin Patches Sales (K Units) and Growth Rate
Table North America Insulin Patches Revenue (M USD) and Growth Rate
Figure North America Insulin Patches Revenue (M USD) and Growth Rate
Table North America CGM Systems Sales (K Units) and Growth Rate
Figure North America CGM Systems Sales (K Units) and Growth Rate
Table North America CGM Systems Revenue (M USD) and Growth Rate
Figure North America CGM Systems Revenue (M USD) and Growth Rate
Table Europe 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Type
Figure Europe Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2013
Figure Europe Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2018
Table Europe 2013-2018 Next Generation Diabetes Therapy and Drug DeliveryRevenue (M USD) by Type
Figure Europe Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2013
Figure Europe Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2018
Table Europe Inhalable Insulin Sales (K Units) and Growth Rate
Figure Europe Inhalable Insulin Sales (K Units) and Growth Rate
Table Europe Inhalable Insulin Revenue (M USD) and Growth Rate
Figure Europe Inhalable Insulin Revenue (M USD) and Growth Rate
Table Europe Oral Insulin Sales (K Units) and Growth Rate
Figure Europe Oral Insulin Sales (K Units) and Growth Rate
Table Europe Oral Insulin Revenue (M USD) and Growth Rate
Figure Europe Oral Insulin Revenue (M USD) and Growth Rate
Table Europe Insulin Patches Sales (K Units) and Growth Rate
Figure Europe Insulin Patches Sales (K Units) and Growth Rate
Table Europe Insulin Patches Revenue (M USD) and Growth Rate
Figure Europe Insulin Patches Revenue (M USD) and Growth Rate
Table Europe CGM Systems Sales (K Units) and Growth Rate
Figure Europe CGM Systems Sales (K Units) and Growth Rate
Table Europe CGM Systems Revenue (M USD) and Growth Rate
Figure Europe CGM Systems Revenue (M USD) and Growth Rate
Table Asia-Pacific 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Type
Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2013
Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2018
Table Asia-Pacific 2013-2018 Next Generation Diabetes Therapy and Drug DeliveryRevenue (M USD) by Type
Figure Asia-Pacific Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2013
Figure Asia-Pacific Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2018
Table Asia-Pacific Inhalable Insulin Sales (K Units) and Growth Rate
Figure Asia-Pacific Inhalable Insulin Sales (K Units) and Growth Rate
Table Asia-Pacific Inhalable Insulin Revenue (M USD) and Growth Rate
Figure Asia-Pacific Inhalable Insulin Revenue (M USD) and Growth Rate
Table Asia-Pacific Oral Insulin Sales (K Units) and Growth Rate
Figure Asia-Pacific Oral Insulin Sales (K Units) and Growth Rate
Table Asia-Pacific Oral Insulin Revenue (M USD) and Growth Rate
Figure Asia-Pacific Oral Insulin Revenue (M USD) and Growth Rate
Table Asia-Pacific Insulin Patches Sales (K Units) and Growth Rate
Figure Asia-Pacific Insulin Patches Sales (K Units) and Growth Rate
Table Asia-Pacific Insulin Patches Revenue (M USD) and Growth Rate
Figure Asia-Pacific Insulin Patches Revenue (M USD) and Growth Rate
Table Asia-Pacific CGM Systems Sales (K Units) and Growth Rate
Figure Asia-Pacific CGM Systems Sales (K Units) and Growth Rate
Table Asia-Pacific CGM Systems Revenue (M USD) and Growth Rate
Figure Asia-Pacific CGM Systems Revenue (M USD) and Growth Rate
Table South America 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Type
Figure South America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2013
Figure South America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2018
Table South America 2013-2018 Next Generation Diabetes Therapy and Drug DeliveryRevenue (M USD) by Type
Figure South America Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2013
Figure South America Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2018
Table South America Inhalable Insulin Sales (K Units) and Growth Rate
Figure South America Inhalable Insulin Sales (K Units) and Growth Rate
Table South America Inhalable Insulin Revenue (M USD) and Growth Rate
Figure South America Inhalable Insulin Revenue (M USD) and Growth Rate
Table South America Oral Insulin Sales (K Units) and Growth Rate
Figure South America Oral Insulin Sales (K Units) and Growth Rate
Table South America Oral Insulin Revenue (M USD) and Growth Rate
Figure South America Oral Insulin Revenue (M USD) and Growth Rate
Table South America Insulin Patches Sales (K Units) and Growth Rate
Figure South America Insulin Patches Sales (K Units) and Growth Rate
Table South America Insulin Patches Revenue (M USD) and Growth Rate
Figure South America Insulin Patches Revenue (M USD) and Growth Rate
Table South America CGM Systems Sales (K Units) and Growth Rate
Figure South America CGM Systems Sales (K Units) and Growth Rate
Table South America CGM Systems Revenue (M USD) and Growth Rate
Figure South America CGM Systems Revenue (M USD) and Growth Rate
Table Middle East and Africa 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Type
Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2013
Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Type in 2018
Table Middle East and Africa 2013-2018 Next Generation Diabetes Therapy and Drug DeliveryRevenue (M USD) by Type
Figure Middle East and Africa Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2013
Figure Middle East and Africa Next Generation Diabetes Therapy and Drug DeliveryRevenue Market Share (%) by Type in 2018
Table Middle East and Africa Inhalable Insulin Sales (K Units) and Growth Rate
Figure Middle East and Africa Inhalable Insulin Sales (K Units) and Growth Rate
Table Middle East and Africa Inhalable Insulin Revenue (M USD) and Growth Rate
Figure Middle East and Africa Inhalable Insulin Revenue (M USD) and Growth Rate
Table Middle East and Africa Oral Insulin Sales (K Units) and Growth Rate
Figure Middle East and Africa Oral Insulin Sales (K Units) and Growth Rate
Table Middle East and Africa Oral Insulin Revenue (M USD) and Growth Rate
Figure Middle East and Africa Oral Insulin Revenue (M USD) and Growth Rate
Table Middle East and Africa Insulin Patches Sales (K Units) and Growth Rate
Figure Middle East and Africa Insulin Patches Sales (K Units) and Growth Rate
Table Middle East and Africa Insulin Patches Revenue (M USD) and Growth Rate
Figure Middle East and Africa Insulin Patches Revenue (M USD) and Growth Rate
Table Middle East and Africa CGM Systems Sales (K Units) and Growth Rate
Figure Middle East and Africa CGM Systems Sales (K Units) and Growth Rate
Table Middle East and Africa CGM Systems Revenue (M USD) and Growth Rate
Figure Middle East and Africa CGM Systems Revenue (M USD) and Growth Rate
Table World 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Application
Figure World Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2013
Figure World Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2018
Table World Diagnostic/Clinics Sales (K Units) and Growth Rate
Figure World Diagnostic/Clinics Sales (K Units) and Growth Rate
Table World ICUs Sales (K Units) and Growth Rate
Figure World ICUs Sales (K Units) and Growth Rate
Table World Home Healthcare Sales (K Units) and Growth Rate
Figure World Home Healthcare Sales (K Units) and Growth Rate
Table North America 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Application
Figure North America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2013
Figure North America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2018
Table North America Diagnostic/Clinics Sales (K Units) and Growth Rate
Figure North America Diagnostic/Clinics Sales (K Units) and Growth Rate
Table North America ICUs Sales (K Units) and Growth Rate
Figure North America ICUs Sales (K Units) and Growth Rate
Table North America Home Healthcare Sales (K Units) and Growth Rate
Figure North America Home Healthcare Sales (K Units) and Growth Rate
Table Europe 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Application
Figure Europe Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2013
Figure Europe Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2018
Table Europe Diagnostic/Clinics Sales (K Units) and Growth Rate
Figure Europe Diagnostic/Clinics Sales (K Units) and Growth Rate
Table Europe ICUs Sales (K Units) and Growth Rate
Figure Europe ICUs Sales (K Units) and Growth Rate
Table Europe Home Healthcare Sales (K Units) and Growth Rate
Figure Europe Home Healthcare Sales (K Units) and Growth Rate
Table Asia-Pacific 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Application
Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2013
Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2018
Table Asia-Pacific Diagnostic/Clinics Sales (K Units) and Growth Rate
Figure Asia-Pacific Diagnostic/Clinics Sales (K Units) and Growth Rate
Table Asia-Pacific ICUs Sales (K Units) and Growth Rate
Figure Asia-Pacific ICUs Sales (K Units) and Growth Rate
Table Asia-Pacific Home Healthcare Sales (K Units) and Growth Rate
Figure Asia-Pacific Home Healthcare Sales (K Units) and Growth Rate
Table South America 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Application
Figure South America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2013
Figure South America Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2018
Table South America Diagnostic/Clinics Sales (K Units) and Growth Rate
Figure South America Diagnostic/Clinics Sales (K Units) and Growth Rate
Table South America ICUs Sales (K Units) and Growth Rate
Figure South America ICUs Sales (K Units) and Growth Rate
Table South America Home Healthcare Sales (K Units) and Growth Rate
Figure South America Home Healthcare Sales (K Units) and Growth Rate
Table Middle East and Africa 2013-2018 Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) by Application
Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2013
Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales Market Share (%) by Application in 2018
Table Middle East and Africa Diagnostic/Clinics Sales (K Units) and Growth Rate
Figure Middle East and Africa Diagnostic/Clinics Sales (K Units) and Growth Rate
Table Middle East and Africa ICUs Sales (K Units) and Growth Rate
Figure Middle East and Africa ICUs Sales (K Units) and Growth Rate
Table Middle East and Africa Home Healthcare Sales (K Units) and Growth Rate
Figure Middle East and Africa Home Healthcare Sales (K Units) and Growth Rate
Table Abbott Laboratories Profiles
Table Abbott Laboratories Product Information
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Medtronic Profiles
Table Medtronic Product Information
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Sanofi Profiles
Table Sanofi Product Information
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Novo Nordisk Profiles
Table Novo Nordisk Product Information
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table MannKind Corporation Profiles
Table MannKind Corporation Product Information
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Enteris BioPharma Profiles
Table Enteris BioPharma Product Information
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Dexcom Profiles
Table Dexcom Product Information
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Senseonics Holding Profiles
Table Senseonics Holding Product Information
Table Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Medtech Profiles
Table Medtech Product Information
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table Johnson & Johnson Profiles
Table Johnson & Johnson Product Information
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Sales Change 2013-2018
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Market Status Change 2013-2018
Table World Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) of Manufacturers 2013-2018
Table World Next Generation Diabetes Therapy and Drug Delivery Sales Share of Manufacturers 2013-2018
Figure World Next Generation Diabetes Therapy and Drug Delivery Sales Share in 2013
Figure World Next Generation Diabetes Therapy and Drug Delivery Sales Share in 2018
Table World Revenue (M USD) of Manufacturers 2013-2018
Table World Revenue Share of Manufacturers 2013-2018
Figure World Revenue Share in 2013
Figure World Revenue Share in 2018
Table World Price (USD/Unit) of Manufacturers 2013-2018
Cross-segment Market Size and Analysis for
Mentioned Segments
